New research published in the bioRxiv* preprint server suggests a small cationic peptide known as crotamine may inhibit the replication and transcription of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Crotamine in the D-enantiomer form successfully inhibited SARS-CoV-2 replication by targeting the C30 Endopeptidase (3CLpro protease).
Crotamine is found in rattlesnake Crotalus durissus terrificus venom and has analgesic, antibacterial, and hemolytic properties. Other drugs, such as Enalapril and Eptifibatide, are based on snake venom and approved by the U.S. Food & Drug Administration.
The advantage of the selected wild type was because of their cell penetration properties, even in D-enantiomer form, high stability and specificity, as well as selectivity against the target 3CL protease was observed,” concluded the research team.
Isolating the peptide and administering it at a low dose may help create a coronavirus disease 2019 (COVID-19) treatment for people with severe illness.
The study
The researchers expressed the SARS-CoV-2 3CLpro_GST fusion protein, needed for viral replication, on E.coli Lemo21 cells and later purified them. The viral protease was exposed to both crotamine and modified peptides with substituted cysteine residues known as L-CDP2-9 to determine the best inhibitor peptide.
First inhibition tests showed that L-CDP1, L-CDP2, L-CDP7, and L-CDP8 peptides had an 80% inhibition against the viral protease. They also tested the minimum concentration needed for crotamine to have a 100% inhibition against the 3CLpro protease. A 100% protease inhibition was achieved at 300 µM.
L-CDP1 caused complete inhibition of SARS-CoV-2 protease activity at 30 µM. A crotamine derivative with an amino acid substitution known as L-peptide-7 caused a 100% inhibition at 60 µM.
Substitutions of cysteine residues, specifically a substitution at position 36, increased L-CDP7’s inhibitory activity.
A fluorescence-based protease assay confirmed the peptide’s conformational shape during inhibition. L-CDP1, L-CDP7, and L-CDP8 peptides were found to be competitive inhibitors.
The results indicate that these peptides interact directly with amino acid residues located in the active site or with amino acids located in the substrate-binding region of the protease, preventing substrate entry to the active site,” explained the researchers.
To protect against degradation in L-enantiomer peptides, the research team created CDP1 and CDP7 in D-enantiomer form. The reasoning was that D peptides are more stable; L-CDP peptides can degrade from hydrolysis by proteases. Because the D-peptides were mirror images of L-peptides, the team predicted that binding affinity and their inhibitory effect should be similar. Results showed D-CDP1 and D-CDP7 are also competitive inhibitors. Though, D-CDP1’s interaction with the SARS-CoV-2 protease is ten times stronger than D-CDP7.
Based on the findings, the team next looked at L-CDP1’s and D-CDP1’s molecular docking efficiency using a web simulation. The simulations showed that amino acid residues of the viral protease interacted with ligand binding, suggesting a potential mode of interaction.
The amino acid residue, His41, appeared to interact with the hydrogen bond of L-CDP1’s Lys31 residues. The remaining amino acid residues are in the substrate-binding region, confirming the interaction is competitive inhibition.
D-CDP1, on the other hand, works by placing the peptide in the substrate-binding region, causing the protease’s active site to be blocked.
*Important notice
bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
The Silent Battle Within: How Your Organs Choose Between Mom and Dad’s Genes
Research reveals that selective expression of maternal or paternal X chromosomes varies by organ, driven by cellular competition. A new study published today (July 26) in Nature Genetics by the Lymphoid Development Group at the MRC [...]
Study identifies genes increasing risk of severe COVID-19
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in [...]
Small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa
Sleep and wake: They're totally distinct states of being that define the boundaries of our daily lives. For years, scientists have measured the difference between these instinctual brain processes by observing brain waves, with [...]
Redefining Consciousness: Small Regions of the Brain Can Take Micro-Naps While the Rest of the Brain Is Awake
The study broadly reveals how fast brain waves, previously overlooked, establish fundamental patterns of sleep and wakefulness. Scientists have developed a new method to analyze sleep and wake states by detecting ultra-fast neuronal activity [...]
AI Reveals Health Secrets Through Facial Temperature Mapping
Researchers have found that different facial temperatures correlate with chronic illnesses like diabetes and high blood pressure, and these can be detected using AI with thermal cameras. They highlight the potential of this technology [...]
Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice
In a recent study published in the journal Nature, a team of researchers used murine models and various pharmacological and genetic approaches to examine whether pro-inflammatory signaling involving interleukin (IL)-11, which activates signaling molecules such [...]
Promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus. The study, [...]
New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do neurons respond to the effects of magic mushrooms? What [...]
Decoding the Decline: Scientific Insights Into Long COVID’s Retreat
Research indicates a significant reduction in long COVID risk, largely due to vaccination and the virus’s evolution. The study analyzes data from over 441,000 veterans, showing lower rates of long COVID among vaccinated individuals compared [...]
Silicon Transformed: A Breakthrough in Laser Nanofabrication
A new method enables precise nanofabrication inside silicon using spatial light modulation and laser pulses, creating advanced nanostructures for potential use in electronics and photonics. Silicon, the cornerstone of modern electronics, photovoltaics, and photonics, [...]
Caught in the actinium: New research could help design better cancer treatments
The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don't have a good grasp on the metal's chemistry. That's because actinium [...]
Innovative Light-Controlled Drugs Could Revolutionize Neuropathic Pain Treatment
A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be harnessed to target drugs to specific [...]
Green Gold: Turning E-Waste Into a Treasure Trove of Rare Earth Metals
Scientists are developing a process inspired by nature that efficiently recovers europium from old fluorescent lamps. The approach could lead to the long-awaited recycling of rare earth metals. A small molecule that naturally serves [...]
Cambridge Study: AI Chatbots Have an “Empathy Gap,” and It Could Be Dangerous
A new study suggests a framework for “Child Safe AI” in response to recent incidents showing that many children perceive chatbots as quasi-human and reliable. A study has indicated that AI chatbots often exhibit [...]
Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy
Up to 3% of people with diabetes have an allergic reaction to insulin. A team at Forschungszentrum Jülich has now studied a method that could be used to deliver the active substance into the [...]
Nanorobot kills cancer cells in mice with hidden weapon
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice. The robot's weapon is hidden in a nanostructure and is exposed only in the tumor microenvironment, sparing healthy cells. [...]